Zhongchao Inc. (ZCMD)
Pre-Market:
| Previous Close | 1.6500 |
| Open | 1.6700 |
| Bid | 1.3200 x 200 |
| Ask | 2.0300 x 200 |
| Day's Range | 1.5500 - 1.8499 |
| 52 Week Range | 1.2000 - 14.0000 |
| Volume | |
| Avg. Volume | 1,005,696 |
| Market Cap | 4.334M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.9700 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Simply Wall St.Zhongchao Full Year 2023 Earnings: US$4.35 loss per share (vs US$1.13 loss in FY 2022)
Zhongchao ( NASDAQ:ZCMD ) Full Year 2023 Results Key Financial Results Revenue: US$19.4m (up 37% from FY 2022). Net...
PR NewswireZhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications
Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that Shanghai Zhongxin Medical Technology Co., Ltd. ("Zhongxin"), of which Zhongchao consolidates the operations and financial results through a series of contractual arrangements, had successfully provided medication assistance services to over 7,000 low-income patients suffering from Systemic Lupus Erythe
PR NewswireZhongchao Inc. Announces 1-for-10 Share Consolidation
Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that an extraordinary general meeting of shareholders held on Tuesday, February 20, 2024, approved the proposed 1-for-10 share consolidation of the Company's ordinary shares of US$0.0001 par value each (the "Share Consolidation").
